mRNA Cancer Vaccine Shows Promise in Treating Aggressive Brain Tumours

A new mRNA cancer vaccine has shown promising results in reprogramming the immune system to attack tumours within 48 hours in a human clinical trial. The vaccine is personalized using the patient's own DNA and has the potential to improve treatment for aggressive brain tumours.

Misinterpretation of Biden's Reference to mRNA Cancer Vaccines

President Joe Biden's reference to mRNA cancer vaccines during his State of the Union address was misinterpreted on social media, leading to false claims that COVID-19 vaccines are being used to cure cancer. In reality, mRNA technology used in COVID-19 vaccines is being studied to treat cancer, with promising results in clinical trials for different types of cancers.

Development of Blood Tests for Mental Health Disorders

Researchers at Johns Hopkins are developing a blood test to detect mental health disorders by analyzing genetic material in human blood. The study focuses on extracellular vesicles carrying specific mRNA linked to brain disorders, aiming to provide a non-invasive diagnostic tool. Another study by Cambridge University combines an online assessment with a blood test to diagnose bipolar disorder accurately. Additionally, scientists at Indiana University have created a blood test to measure anxiety objectively and identify effective treatment options. Yale University researchers have identified 170 genes linked to depression, potentially leading to a blood test for diagnosis and personalized treatment.